|
[Related PubMed/MEDLINE]
Total Number of Papers: 139
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium. |
PACAP, UVB |
| 2 |
2022 |
All in the Family: Living With ADNP Syndrome. |
--- |
| 3 |
2022 |
DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients. |
AD, aDS, DS |
| 4 |
2022 |
Proximity labeling identifies a repertoire of site-specific R-loop modulators. |
--- |
| 5 |
2022 |
SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism. |
ELM, MT, SH3, SHANK3 |
| 6 |
2022 |
The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease. |
BDNF, CNS, D3R, PACAP, PD, VIP |
| 7 |
2021 |
Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy. |
aMCI, EBs, MTs, NAP, PSP, Tau3R, Tau4R |
| 8 |
2021 |
ADNP prompts the cisplatin-resistance of bladder cancer via TGF-beta-mediated epithelial-mesenchymal transition (EMT) pathway. |
BC, CCK-8, EMT, IHC, qRT-PCR |
| 9 |
2021 |
Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation. |
AD, MAPRE1, SIRT1 |
| 10 |
2021 |
PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy. |
PACAP |
| 11 |
2021 |
Sensory Reactivity Symptoms Are a Core Feature of ADNP Syndrome Irrespective of Autism Diagnosis. |
ASD |
| 12 |
2021 |
Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging. |
GNMT, GNMT-KO, GnRH, SAMe |
| 13 |
2021 |
Zinc Binding to NAP-Type Neuroprotective Peptides: Nuclear Magnetic Resonance Studies and Molecular Modeling. |
AD, MALDI ToF, MS, NMR |
| 14 |
2020 |
ADNP Controls Gene Expression Through Local Chromatin Architecture by Association With BRG1 and CHD4. |
PrE |
| 15 |
2020 |
ADNP promotes neural differentiation by modulating Wnt/beta-catenin signaling. |
--- |
| 16 |
2020 |
ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway. |
BC, CCK-8, qRT-PCR |
| 17 |
2020 |
Age and Sex-Dependent ADNP Regulation of Muscle Gene Expression Is Correlated with Motor Behavior: Possible Feedback Mechanism with PACAP. |
FOXP2, GC, MYL, PACAP |
| 18 |
2020 |
Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype. |
HVDAS |
| 19 |
2020 |
Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond. |
Bac, Bif, Coer, MIB |
| 20 |
2020 |
Sex-and Region-Dependent Expression of the Autism-Linked ADNP Correlates with Social- and Speech-Related Genes in the Canary Brain. |
FoxP2, VIP, ZF |
| 21 |
2020 |
Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting. |
male |
| 22 |
2020 |
Tauopathy in the young autistic brain: novel biomarker and therapeutic target. |
ASD, ID, MAPT |
| 23 |
2020 |
The ADNP Syndrome and CP201 (NAP) Potential and Hope. |
--- |
| 24 |
2020 |
VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects. |
D-SKIP, EB, MWM, PACAP, VIP |
| 25 |
2019 |
A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP. |
ADNF, EBs |
| 26 |
2019 |
ADNP differentially interact with genes/proteins in correlation with aging: a novel marker for muscle aging. |
CDC5L |
| 27 |
2019 |
Atypical Auditory Brainstem Response and Protein Expression Aberrations Related to ASD and Hearing Loss in the Adnp Haploinsufficient Mouse Brain. |
ABR, ASD |
| 28 |
2019 |
Direct evidence for binding of aluminum to NAP anti-amyloid peptide and its analogs. |
FTIR, MS |
| 29 |
2019 |
Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study. |
AD, ID, MT |
| 30 |
2019 |
NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies. |
MT |
| 31 |
2019 |
Neuroprotective Peptide NAPVSIPQ Antagonizes Ethanol Inhibition of L1 Adhesion by Promoting the Dissociation of L1 and Ankyrin-G. |
NAP |
| 32 |
2019 |
The autism-mutated ADNP plays a key role in stress response. |
PACAP, VIP |
| 33 |
2019 |
The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse. |
DTI, VGLUT1 |
| 34 |
2018 |
Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice. |
--- |
| 35 |
2018 |
Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome. |
--- |
| 36 |
2018 |
Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes. |
--- |
| 37 |
2018 |
NAP Protects against Tau Hyperphosphorylation Through GSK3. |
AD, GSK-3beta, NFT |
| 38 |
2017 |
ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease. |
AD, ASD |
| 39 |
2017 |
ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy. |
EB, MAPs, MAPs, MT |
| 40 |
2017 |
Davunetide improves spatial learning and memory in Alzheimer's disease-associated rats. |
AD, LTP, MWM, PPF |
| 41 |
2017 |
Interaction between FMDV Lpro and transcription factor ADNP is required for optimal viral replication. |
FMDV, IFN, Lpro |
| 42 |
2017 |
NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression. |
BRB, DME |
| 43 |
2017 |
Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children. |
ASD, RNA-Seq |
| 44 |
2017 |
Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress. |
AD, RGS2 |
| 45 |
2017 |
The Eight and a Half Year Journey of Undiagnosed AD: Gene Sequencing and Funding of Advanced Genetic Testing Has Led to Hope and New Beginnings. |
--- |
| 46 |
2016 |
Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease. |
PD |
| 47 |
2016 |
D-SAL and NAP: Two Peptides Sharing a SIP Domain. |
ADNF, D-SAL, EBs, NAP |
| 48 |
2016 |
Impairment of mitochondria dynamics by human A53T alpha-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease. |
--- |
| 49 |
2016 |
Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats. |
GABA, GAD, GFAP, Glu, HPLC, VIP |
| 50 |
2016 |
Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease. |
MCI |
| 51 |
2016 |
Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory. |
ASD, BECN1, EBs |
| 52 |
2015 |
Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies. |
AD, ASD, eIF4E |
| 53 |
2015 |
Activity-dependent neuroprotective protein (ADNP): from autism to Alzheimer's disease. |
--- |
| 54 |
2015 |
ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment. |
DRG, MAP, mRNA |
| 55 |
2015 |
ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration. |
AD, FTDs, PSP, SWI/SNF |
| 56 |
2015 |
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naive humans with multiple sclerosis. |
BDNF, CNS, MS, VIP |
| 57 |
2015 |
Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers. |
AD, MCI |
| 58 |
2015 |
In vivo and in vitro ketamine exposure exhibits a dose-dependent induction of activity-dependent neuroprotective protein in rat neurons. |
3 DIV |
| 59 |
2015 |
Novel hexapeptide interacts with tubulin and microtubules, inhibits Abeta fibrillation, and shows significant neuroprotection. |
NGF |
| 60 |
2015 |
Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model. |
DISC1, EB, Foxp2 |
| 61 |
2015 |
The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP. |
EB, LC3 |
| 62 |
2014 |
Activity-dependent neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer. |
AD |
| 63 |
2014 |
Davunetide: Peptide therapeutic in neurological disorders. |
--- |
| 64 |
2014 |
NAP alpha-aminoisobutyric acid (IsoNAP). |
AD |
| 65 |
2014 |
Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation. |
BRM, FTDs, PTB, SWI/SNF |
| 66 |
2014 |
The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. |
MT, PSD-95 |
| 67 |
2013 |
Autophagy has a key role in the pathophysiology of schizophrenia. |
LC3 |
| 68 |
2013 |
Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP). |
--- |
| 69 |
2012 |
D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy. |
ALS |
| 70 |
2012 |
Ethanol disrupts axon outgrowth stimulated by netrin-1, GDNF, and L1 by blocking their convergent activation of Src family kinase signaling. |
BDNF, CGN, FASD, GDNF, SFK |
| 71 |
2012 |
Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells. |
MPNST, MPNSTs, NS, PACAP, SS |
| 72 |
2012 |
Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP). |
--- |
| 73 |
2012 |
Novel evolutionary-conserved role for the activity-dependent neuroprotective protein (ADNP) family that is important for erythropoiesis. |
DMSO, MEL |
| 74 |
2012 |
Strategies to defeat ketamine-induced neonatal brain injury. |
AC3, NAP |
| 75 |
2012 |
The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities. |
MTs |
| 76 |
2011 |
Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain. |
--- |
| 77 |
2011 |
Activity-dependent neuroprotective protein modulates its own gene expression. |
--- |
| 78 |
2011 |
Ameliorative effect of NAP on laser-induced retinal damage. |
--- |
| 79 |
2011 |
HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats. |
PTM |
| 80 |
2011 |
Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). |
MAP2, PSP |
| 81 |
2011 |
NAP (davunetide) provides functional and structural neuroprotection. |
--- |
| 82 |
2011 |
Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects. |
ADNF, SAL |
| 83 |
2010 |
Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia. |
--- |
| 84 |
2010 |
Expression of peptide NAP in rat retinal Muller cells prevents hypoxia-induced retinal injuries and promotes retinal neurons growth. |
NT4, RMC |
| 85 |
2010 |
Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate. |
STOP |
| 86 |
2010 |
NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia. |
STOP |
| 87 |
2010 |
Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy. |
--- |
| 88 |
2010 |
Tau pathology and future therapeutics. |
AD, CBD, FTD, PSP |
| 89 |
2010 |
The effects of nitric oxide inhibition prior to kainic acid treatment on neuro- and gliogenesis in the rat dentate gyrus in vivo and in vitro. |
KA, NOS, SGZ |
| 90 |
2010 |
VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina. |
BDNF, NMDA, PACAP-38, VIP |
| 91 |
2009 |
Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. |
AD, VIP, WT |
| 92 |
2009 |
NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42). |
ADNF-9 |
| 93 |
2009 |
NAP protects against cytochrome c release: inhibition of the initiation of apoptosis. |
NAP |
| 94 |
2009 |
Nitric oxide regulates activity-dependent neuroprotective protein (ADNP) in the dentate gyrus of the rodent model of kainic acid-induced seizure. |
7-NI, DG, KA, NO |
| 95 |
2008 |
ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance. |
--- |
| 96 |
2008 |
Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling. |
Cas, CNS, NAP |
| 97 |
2008 |
NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. |
--- |
| 98 |
2008 |
Peptidergic agonists of activity-dependent neurotrophic factor protect against prenatal alcohol-induced neural tube defects and serotonin neuron loss. |
ADNF, NAP, SAL |
| 99 |
2008 |
Regulation of activity-dependent neuroprotective protein (ADNP) by the NO-cGMP pathway in the hippocampus during kainic acid-induced seizure. |
iNOS, KA, nNOS, sGC |
| 100 |
2008 |
Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress. |
--- |
|
A Search Service for Abbreviation / Long Form
